Some of the most common progression events in MM include mutations in the driver genes, such as rat sarcoma virus (RAS) mutations, proto-oncogene MYC dysregulation through SVs, and a variety of mutations that inactivate the NFKB pathway, but there are many other important genes that lead to progression [3]. The gene discussed is MYC; the disease is Miyoshi myopathy.